REGENXBIO Inc.RGNXNASDAQ
Loading
Year-over-year net income growth rate
Percentile
P46
Within normal range
vs 3Y Ago
-0.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -8.41% |
| Q3 2025 | 12.60% |
| Q2 2025 | -1265.07% |
| Q1 2025 | 111.88% |
| Q4 2024 | 14.11% |
| Q3 2024 | -12.47% |
| Q2 2024 | 16.33% |
| Q1 2024 | -0.70% |
| Q4 2023 | -1.65% |
| Q3 2023 | 14.14% |
| Q2 2023 | -8.08% |
| Q1 2023 | -11.25% |
| Q4 2022 | 20.60% |
| Q3 2022 | -10.71% |
| Q2 2022 | 11.14% |
| Q1 2022 | -126.09% |
| Q4 2021 | 603.42% |
| Q3 2021 | -1.33% |
| Q2 2021 | -14.96% |
| Q1 2021 | -8.43% |
| Q4 2020 | -626.00% |
| Q3 2020 | 126.04% |
| Q2 2020 | 15.68% |
| Q1 2020 | -51.29% |
| Q4 2019 | 23.48% |
| Q3 2019 | -2273.64% |
| Q2 2019 | 95.48% |
| Q1 2019 | -848.44% |
| Q4 2018 | 122.42% |
| Q3 2018 | -281.25% |
| Q2 2018 | -89.84% |
| Q1 2018 | 751.62% |
| Q4 2017 | 22.74% |
| Q3 2017 | -43.07% |
| Q2 2017 | 34.19% |
| Q1 2017 | -12.16% |
| Q4 2016 | -8.01% |
| Q3 2016 | -25.75% |
| Q2 2016 | -34.07% |
| Q1 2016 | -107.96% |